Second Trial Of Controversial Chelation Therapy Gains Crucial Early Support

The National Institutes of Health is giving money to support the planning of a second trial to test the potential role of chelation therapy in treating patients with myocardial infarction. The first Trial to Assess Chelation Therapy (TACT) was extremely controversial. It was funded by the NIH more than a dozen ago as part of an initiative to...Click here to continue reading...
Source: CardioBrief - Category: Cardiology Authors: Tags: Diabetes MI/ACS People, Places & Events Policy & Ethics alternative medicine chelation NIH TACT Source Type: blogs